According to the previous reports, CCDC124 was significantly overexpressed in endometrial cancer (EC), hepatocellular carcinoma (HCC), colorectal cancer (CRC), and ovarian cancer (OC) was related to tumor cell division, tumor heterogeneity and drug resistance (Lu et al., 2020; Arslan et al., 2021). Here, CCDC124 is linked to hepatocellular carcinoma.